Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,019) with videos related to
Page
of 102
Sort By:
British Journal of Haematology
|
March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab
David J Allsup, David A Cairns, E Faye Samy, et al.
Trials
|
January 20, 2019
Evaluating the efficacy of Seattle-PAP for the respiratory support of premature neonates: study protocol for a randomized controlled trial
Carl H Backes, Jennifer L Notestine, Jane M Lamp, et al.
Aerosol Science and Technology : the Journal of the American Association for Aerosol Research
|
May 23, 2022
Experimental verification of principal losses in a regulatory particulate matter emissions sampling system for aircraft turbine engines
D B Kittelson, J Swanson, M Aldridge, et al.
Emerging Infectious Diseases
|
January 30, 2026
Group A Streptococcus Meningitis, United States, 1997-2022
Paulina A Hawkins, Sopio Chochua, Namrata Prasad, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
May 21, 2020
A trial comparing continuous positive airway pressure (CPAP) devices in preterm infants
Carl H Backes, Jennifer N Cooper, Jennifer L Notestine, et al.
Blood Advances
|
August 23, 2019
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil, et al.
Nature Communications
|
May 14, 2021
Antigen-driven EGR2 expression is required for exhausted CD8<sup>+</sup> T cell stability and maintenance
Mayura V Wagle, Stephin J Vervoort, Madison J Kelly, et al.
The Lancet. Oncology
|
May 4, 2023
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Peter Hillmen, Alexandra Pitchford, Adrian Bloor, et al.
European Journal of Endocrinology
|
April 7, 2025
Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty
Raíssa C Rezende, Wen He, Lena R Kaisinger, et al.
Immunity
|
April 1, 2023
Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection
Md Al Amin Sikder, Ridwan B Rashid, Tufael Ahmed, et al.
Page
of 102
Search research articles
Search
Showing results (1001-1010 of 1,019) with videos related to
Sort By:
Page
of 102
British Journal of Haematology
|
March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab
David J Allsup, David A Cairns, E Faye Samy, et al.
Trials
|
January 20, 2019
Evaluating the efficacy of Seattle-PAP for the respiratory support of premature neonates: study protocol for a randomized controlled trial
Carl H Backes, Jennifer L Notestine, Jane M Lamp, et al.
Aerosol Science and Technology : the Journal of the American Association for Aerosol Research
|
May 23, 2022
Experimental verification of principal losses in a regulatory particulate matter emissions sampling system for aircraft turbine engines
D B Kittelson, J Swanson, M Aldridge, et al.
Emerging Infectious Diseases
|
January 30, 2026
Group A Streptococcus Meningitis, United States, 1997-2022
Paulina A Hawkins, Sopio Chochua, Namrata Prasad, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
May 21, 2020
A trial comparing continuous positive airway pressure (CPAP) devices in preterm infants
Carl H Backes, Jennifer N Cooper, Jennifer L Notestine, et al.
Blood Advances
|
August 23, 2019
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil, et al.
Nature Communications
|
May 14, 2021
Antigen-driven EGR2 expression is required for exhausted CD8<sup>+</sup> T cell stability and maintenance
Mayura V Wagle, Stephin J Vervoort, Madison J Kelly, et al.
The Lancet. Oncology
|
May 4, 2023
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Peter Hillmen, Alexandra Pitchford, Adrian Bloor, et al.
European Journal of Endocrinology
|
April 7, 2025
Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty
Raíssa C Rezende, Wen He, Lena R Kaisinger, et al.
Immunity
|
April 1, 2023
Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection
Md Al Amin Sikder, Ridwan B Rashid, Tufael Ahmed, et al.
Page
of 102